Recombinant Human RABL4 Protein，GST

RABL4, a member of the Ras-related protein family, plays a crucial role in various cellular processes, including cell proliferation, migration, and differentiation. Its involvement in the regulation of the cytoskeleton and vesicle trafficking highlights its significance in maintaining cellular homeostasis. Recent studies have indicated that RABL4 is highly expressed in several cancer types, suggesting its potential as a biomarker for tumor progression and a target for therapeutic intervention. Researchers have focused on the structural and functional characterization of RABL4 to understand its mechanism of action and contribution to oncogenic pathways. The development of RABL4 recombinant proteins has been pivotal in these studies, allowing for the exploration of its interactions with other cellular molecules, such as GTPases and downstream signaling partners. By utilizing advanced techniques like X-ray crystallography and cryo-electron microscopy, scientists aim to elucidate the three-dimensional structure of RABL4 and its binding affinities, offering insights into drug design. Additionally, understanding the regulatory networks involving RABL4 could reveal novel therapeutic strategies for cancer treatment and other diseases linked to cellular dysfunctions. Through these efforts, RABL4 may emerge as a promising candidate for targeted therapies, contributing to advancements in personalized medicine and improved treatment outcomes. As research progresses, the implications of RABL4 in both basic and translational science continue to expand, emphasizing the importance of this protein in the broader context of cell biology and cancer research.